BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Armstrong SP, Seeber RM, Ayoub MA, Feldman BJ, Pfleger KD. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V). PLoS One 2013;8:e65885. [PMID: 23762448 DOI: 10.1371/journal.pone.0065885] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Burford NT, Watson J, Alt A. Standard Curves Are Necessary to Determine Pharmacological Properties for Ligands in Functional Assays Using Competition Binding Technologies. Assay Drug Dev Technol 2017;15:320-9. [PMID: 29120673 DOI: 10.1089/adt.2017.811] [Reference Citation Analysis]
2 Ayoub MA. Resonance Energy Transfer-Based Approaches to Study GPCRs. Methods Cell Biol 2016;132:255-92. [PMID: 26928548 DOI: 10.1016/bs.mcb.2015.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
3 Johnstone EK, Pfleger KD. Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling. Methods Mol Biol 2015;1335:191-204. [PMID: 26260602 DOI: 10.1007/978-1-4939-2914-6_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ayoub MA, Trebaux J, Vallaghe J, Charrier-Savournin F, Al-Hosaini K, Gonzalez Moya A, Pin JP, Pfleger KD, Trinquet E. Homogeneous time-resolved fluorescence-based assay to monitor extracellular signal-regulated kinase signaling in a high-throughput format. Front Endocrinol (Lausanne) 2014;5:94. [PMID: 25002860 DOI: 10.3389/fendo.2014.00094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
5 Klinck J, Mcneill L, Di Angelantonio E, Menon D. Predictors and outcome impact of perioperative serum sodium changes in a high-risk population. British Journal of Anaesthesia 2015;114:615-22. [DOI: 10.1093/bja/aeu409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
6 Okashah N, Wright SC, Kawakami K, Mathiasen S, Zhou J, Lu S, Javitch JA, Inoue A, Bouvier M, Lambert NA. Agonist-induced formation of unproductive receptor-G12 complexes. Proc Natl Acad Sci U S A 2020;117:21723-30. [PMID: 32817560 DOI: 10.1073/pnas.2003787117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Mancinelli R, Franchitto A, Glaser S, Vetuschi A, Venter J, Sferra R, Pannarale L, Olivero F, Carpino G, Alpini G, Onori P, Gaudio E. Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease. Lab Invest 2016;96:1147-55. [PMID: 27571215 DOI: 10.1038/labinvest.2016.93] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
8 Ng HK, Harikumar KG, Miller LJ, Chow BK. Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus. PLoS One 2016;11:e0163086. [PMID: 27649563 DOI: 10.1371/journal.pone.0163086] [Reference Citation Analysis]
9 Knoers NVAM, Levtchenko EN. Nephrogenic Diabetes Insipidus in Children. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, editors. Pediatric Nephrology. Berlin: Springer Berlin Heidelberg; 2016. pp. 1307-27. [DOI: 10.1007/978-3-662-43596-0_36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Ayoub MA, Zhang Y, Kelly RS, See HB, Johnstone EK, McCall EA, Williams JH, Kelly DJ, Pfleger KD. Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease. PLoS One 2015;10:e0119803. [PMID: 25807547 DOI: 10.1371/journal.pone.0119803] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
11 García Castaño A, Pérez de Nanclares G, Madariaga L, Aguirre M, Chocron S, Madrid A, Lafita Tejedor FJ, Gil Campos M, Sánchez Del Pozo J, Ruiz Cano R, Espino M, Gomez Vida JM, Santos F, García Nieto VM, Loza R, Rodríguez LM, Hidalgo Barquero E, Printza N, Camacho JA, Castaño L, Ariceta G; RenalTube Group. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study. Eur J Pediatr. 2015;174:1373-1385. [PMID: 25902753 DOI: 10.1007/s00431-015-2534-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
12 Tiulpakov A, White CW, Abhayawardana RS, See HB, Chan AS, Seeber RM, Heng JI, Dedov I, Pavlos NJ, Pfleger KD. Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking. Mol Endocrinol 2016;30:889-904. [PMID: 27355191 DOI: 10.1210/me.2016-1002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
13 Erdélyi LS, Mann WA, Morris-Rosendahl DJ, Groß U, Nagel M, Várnai P, Balla A, Hunyady L. Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis. Kidney Int 2015;88:1070-8. [PMID: 26131744 DOI: 10.1038/ki.2015.181] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
14 Sanchez-Soto M, Verma RK, Willette BKA, Gonye EC, Moore AM, Moritz AE, Boateng CA, Yano H, Free RB, Shi L, Sibley DR. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Sci Signal 2020;13:eaaw5885. [PMID: 32019899 DOI: 10.1126/scisignal.aaw5885] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
15 Lu TL, Chang WT, Chan CH, Wu SN. Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor. Front Pharmacol 2019;10:76. [PMID: 30873020 DOI: 10.3389/fphar.2019.00076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
16 Janovick JA, Spicer TP, Bannister TD, Scampavia L, Conn PM. Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias. PLoS One 2017;12:e0181830. [PMID: 28767678 DOI: 10.1371/journal.pone.0181830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
17 Jaeger WC, Armstrong SP, Hill SJ, Pfleger KD. Biophysical Detection of Diversity and Bias in GPCR Function. Front Endocrinol (Lausanne) 2014;5:26. [PMID: 24634666 DOI: 10.3389/fendo.2014.00026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
18 Schernthaner-Reiter MH, Stratakis CA, Luger A. Genetics of Diabetes Insipidus. Endocrinol Metab Clin North Am 2017;46:305-34. [PMID: 28476225 DOI: 10.1016/j.ecl.2017.01.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Velásquez-Jones L, Medeiros-Domingo M. [Nephrogenic diabetes insipidus]. Bol Med Hosp Infant Mex 2014;71:332-8. [PMID: 29421628 DOI: 10.1016/j.bmhimx.2015.01.004] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Ibsen MS, Finlay DB, Patel M, Javitch JA, Glass M, Grimsey NL. Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence. Front Pharmacol 2019;10:350. [PMID: 31024316 DOI: 10.3389/fphar.2019.00350] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
21 Yang LK, Hou ZS, Tao YX. Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases. Biochim Biophys Acta Mol Basis Dis 2021;1867:165973. [PMID: 32949766 DOI: 10.1016/j.bbadis.2020.165973] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]